For in vitro & in vivo laboratory research use only. Not for human or animal use. Not FDA-approved.
CJC-1295 (with DAC) 2mg
Modified GHRH analogue with Drug Affinity Complex (DAC) for extended plasma half-life. Studied in vitro for GHRH receptor binding and sustained somatotroph signaling research.
All products sold strictly for in vitro & in vivo laboratory research use only. Not for human or animal use. Not FDA-approved.
FREQUENTLY ASKED QUESTIONS
This product has been independently verified at 98.9% purity via HPLC analysis. A full Certificate of Analysis (COA) is available in our COA Library.
RELATED COMPOUNDS
Ipamorelin (5mg)
Selective pentapeptide growth hormone secretagogue. Studied in vitro for GH-releasing peptide receptor (GHRP-2) binding and pituitary cell signaling research. 5-panel verified.
Ipamorelin (10mg)
Selective pentapeptide growth hormone secretagogue. Studied in vitro for GH-releasing peptide receptor (GHRP-2) binding and pituitary cell signaling research. 5-panel verified.
CJC-1295 (No DAC) 5mg
Modified GHRH analogue (GRF 1-29) without Drug Affinity Complex. Studied in vitro for GHRH receptor binding and pulsatile somatotroph signaling research.
CJC-1295 (No DAC) 10mg
Modified GHRH analogue (GRF 1-29) without Drug Affinity Complex. Studied in vitro for GHRH receptor binding and pulsatile somatotroph signaling research.
FOR RESEARCH USE ONLY. This product is strictly for in vitro and in vivo laboratory research purposes only. Not for human or animal use. Not an FDA-approved drug. Not intended to diagnose, treat, cure, or prevent any disease or condition.